tailieunhanh - Biosafety issues in commercialization and development of transgenic crops

Application of transgenic technology for commercial crop production is faced with biosafety issues. These concerns are based on the argument that recombinant DNA-based transgenic technology differs from traditional breeding in that totally new gens using potentially risky technology are transferred between widely unrelated organisms and the location of these genes on the recipient genome is random, unlike when gene transfer take place through conventional breeding. These differences demands that adequate laboratory safeguards are used and plant developed by GM technology are rigorously assessed for their performance as also for the likely risks they pose. | Biosafety issues in commercialization and development of transgenic crops

crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.